{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T04:40:32Z","timestamp":1768624832774,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["3 Biotech"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>AUNIP (Aurora kinase A[Aurora-A] and ninein-interacting protein), is a key factor regulating the end-state of DNA cleavage. It has been reported that AUNIP affects the progression of some tumors; however, the molecular functions involved in AUNIP remain unknown. We employed some databases, such as TCGA, GTEx, TIMER, GEPIA2, cBioportal, and GSCALite, to study AUNIP gene expression, prognosis, gene variation, and drug sensitivity. The relationship between AUNIP and clinicopathological information was explored using Wilcoxon test. The association between AUNIP and TMB, MSI, immunocyte infiltration, and immune checkpoints were analyzed using Spearman correlation analysis. We employed GSEA to research the functional mechanisms involved in AUNIP for pan-cancer. Moreover, we conducted immunohistochemistry (IHC) to investigate AUNIP difference expression between liver hepatocellular carcinoma (LIHC) and normal tissues. The Chisq test was used to study the correlation of AUNIP with clinical characteristics. AUNIP was highly expressed in majority of tumors and IHC analysis demonstrated that AUNIP expression was higher in LIHC than normal tissues. AUNIP overexpression had adverse outcomes in adrenocortical carcinoma (ACC), brain lower grade glioma (LGG), LIHC, mesothelioma (MESO), and sarcoma (SARC). Furthermore, high AUNIP expression led to unfavorable prognosis in LIHC. AUNIP was associated with T stage, N stage, and clinicopathological analysis in several cancers and AUNIP expression had a correlation with histologic grade in LIHC by IHC. Mutation analysis showed that AUNIP was the highest frequency of genetic changes in cholangiocarcinoma (CHOL). AUNIP was negatively associated with 30 small-molecule drugs that inhibit tumor development. AUNIP expression had association with TMB, MSI, immune cell infiltration, and immune checkpoints for various tumors. GSEA results suggested that AUNIP mainly participated in the cell cycle, DNA replication, mismatch repair, and homologous recombination.Pan-cancer study considered AUNIP as a potential prognostic marker and high latent diagnostic biomarker.<\/jats:p>","DOI":"10.1007\/s13205-025-04294-6","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T18:05:49Z","timestamp":1747505149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AUNIP was a candidate marker for prognosis and immunology in pan-cancer"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4727-2981","authenticated-orcid":false,"given":"Xiaorong","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"issue":"4","key":"4294_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jclinpath-2020-207281","volume":"74","author":"AC Bateman","year":"2021","unstructured":"Bateman AC (2021) DNA mismatch repair proteins: scientific update and practical guide[J]. J Clin Pathol 74(4):264\u2013268","journal-title":"J Clin Pathol"},{"key":"4294_CR2","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.dnarep.2006.05.026","volume":"5","author":"S Burma","year":"2006","unstructured":"Burma S, Chen BP, Chen DJ (2006) Role of non-homologous and joining (NHEJ) in maintaining genomic integrity. DNA Repair (Amst) 5:1042\u20131048","journal-title":"DNA Repair (Amst)"},{"key":"4294_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401\u2013404","journal-title":"Cancer Discov"},{"issue":"1","key":"4294_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","volume":"30","author":"TA Chan","year":"2019","unstructured":"Chan TA, Yarchoan M, Jaffee E et al (2019) Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic[J]. Ann Oncol 30(1):44\u201356","journal-title":"Ann Oncol"},{"key":"4294_CR5","unstructured":"Chou CH, Loh JK, Yang MC, Lin CC, Hong MC, Cho CL, et al. AIBp regulates mitotic entry and mitotic spindle assembly by controlling activation of both Aurora-A and Plk1"},{"issue":"4","key":"4294_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/1078-0432.CCR-15-1678","volume":"22","author":"JC Dudley","year":"2016","unstructured":"Dudley JC, Le DT et al (2016) Microsatellite instability as a biomarker for PD-1 blockade[J]. Clin Cancer Res 22(4):813\u2013820","journal-title":"Clin Cancer Res"},{"key":"4294_CR7","doi-asserted-by":"crossref","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B and Shirley Liu X (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res","DOI":"10.1093\/nar\/gkaa407"},{"key":"4294_CR8","first-page":"429","volume":"37","author":"A Lieu","year":"2010","unstructured":"Lieu A, Cheng T, Chou C et al (2010) Functional characterization of AIBp, a novel Aurora-A binding protein in centrosome structure and spindle formation. Int J Oncol 37:429\u2013436","journal-title":"Int J Oncol"},{"issue":"24","key":"4294_CR9","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1158\/1078-0432.CCR-19-0558","volume":"25","author":"L Liu","year":"2019","unstructured":"Liu L, Bai X, Wang J et al (2019) Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer [J]. Clin Cancer Res 25(24):7413\u20137423","journal-title":"Clin Cancer Res"},{"key":"4294_CR10","doi-asserted-by":"crossref","unstructured":"Liu C-J, Hu F-F, Xie G-Y, Miao Y_R, Li X-W, Zeng Y, Guo A-Y (2022) GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic, and immunogenomic levels. Briefings Bioinform bbac558","DOI":"10.1093\/bib\/bbac558"},{"issue":"1","key":"4294_CR11","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41467-017-01151-w","volume":"8","author":"J Lou","year":"2017","unstructured":"Lou J, Chen H, Han J, He H, Huen MSY, Feng X-H, Liu T, Huang J (2017) AUNIP\/C1orf135 directs DNA double-strand breaks towards the homologous recombination repair pathway. Nat Commun 8(1):985","journal-title":"Nat Commun"},{"key":"4294_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.590006","volume":"10","author":"C Ma","year":"2020","unstructured":"Ma C, Kang W, Yu L et al (2020) AUNIP expression is correlated with immune infiltration and is a candidate diagnostic and prognostic biomarker for hepatocellular carcinoma and lung adenocarcinoma. Front Oncol 10:Article 590006","journal-title":"Front Oncol"},{"issue":"3","key":"4294_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nm.4508","volume":"24","author":"A Marcas","year":"2018","unstructured":"Marcas A, Walzer T (2018) An immunosuppressive pathway for tumor progression [J]. Nat Med 24(3):260","journal-title":"Nat Med"},{"key":"4294_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/diagnostics13050965","volume":"13","author":"D Mishra","year":"2023","unstructured":"Mishra D, Mishra A, Rai SN, Vamanu E, Singh MP (2023a) Identification of prognostic biomarkers for suppressing tumorigenesis and metastasis of hepatocellular carcinoma through transcriptome analysis. Diagnostics 13:965","journal-title":"Diagnostics"},{"key":"4294_CR15","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3390\/diagnostics13061142","volume":"13","author":"D Mishra","year":"2023","unstructured":"Mishra D, Mishra A, Rai SN, Vamanu E, Singh MP (2023b) Demystifying the role of prognostic biomarkers in breast cancer through integrated transcriptome and pathway enrichment analyses. Diagnostics 13:1142","journal-title":"Diagnostics"},{"issue":"7","key":"4294_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.31083\/j.fbl2807151","volume":"28","author":"D Mishra","year":"2023","unstructured":"Mishra D, Mishra A, Rai S, Singh S, Vamanu E, Singh MP (2023c) In Silico Insight to Identify Potential Inhibitors of BUB1B from Mushroom Bioactive Compounds to Prevent Breast Cancer Metastasis. Front. Biosci. Landmark Ed 28(7):151","journal-title":"Front. Biosci. Landmark Ed"},{"issue":"1","key":"4294_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1479-5876-3-9","volume":"3","author":"MA Morse","year":"2005","unstructured":"Morse MA, Garst J, Osada T et al (2005) A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer [J]. J Transl Med 3(1):9","journal-title":"J Transl Med"},{"issue":"47","key":"4294_CR18","doi-asserted-by":"crossref","first-page":"23662","DOI":"10.1073\/pnas.1906026116","volume":"116","author":"A Nabbi","year":"2019","unstructured":"Nabbi A, Jager N, Sudhaman S et al (2019) Landscape of infiltrating immune repertoire in pediatric solid tumors[J]. Proc Natl Acad Sci 116(47):23662\u201323670","journal-title":"Proc Natl Acad Sci"},{"issue":"17","key":"4294_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/ijgc-00009577-200707000-00019","volume":"4","author":"A Sharma","year":"2007","unstructured":"Sharma A, Rajappa M, Saxena A et al (2007) Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix[J]. Int J Gynecol Cancer 4(17):879\u2013885","journal-title":"Int J Gynecol Cancer"},{"key":"4294_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz430","author":"Z Tang","year":"2019","unstructured":"Tang Z et al (2019) GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkz430","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"4294_CR21","first-page":"23","volume":"45","author":"L Yang","year":"2018","unstructured":"Yang L, Yang S, Yuan X et al (2018) Analyzing pan-cancer DNA methylation patterns via clustering[J]. J Xidian Univ 45(4):23\u201328","journal-title":"J Xidian Univ"},{"key":"4294_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ebiom.2019.08.013","volume":"47","author":"Z Yang","year":"2019","unstructured":"Yang Z, Liang X, Fu Y et al (2019) Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma. EBioMedicine 47:44\u201357","journal-title":"EBioMedicine"},{"issue":"4","key":"4294_CR23","first-page":"219","volume":"18","author":"K Zhang","year":"2015","unstructured":"Zhang K, Wang H (2015) Cancer genome atlas pan-cancer analysis project[J]. Zhongguo Fei Ai Za Zhi 18(4):219\u2013223","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"22","key":"4294_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.21037\/atm.2019.10.84","volume":"7","author":"C Zhang","year":"2019","unstructured":"Zhang C, Li Z, Qi F et al (2019) Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma[J]. Ann Transl Med 7(22):648","journal-title":"Ann Transl Med"},{"issue":"4","key":"4294_CR25","first-page":"247","volume":"1","author":"J Zhou","year":"2004","unstructured":"Zhou J, Zhong Y (2004) Breast cancer immunotherapy [J]. Cell Mol Immunol 1(4):247\u2013255","journal-title":"Cell Mol Immunol"}],"container-title":["3 Biotech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-025-04294-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13205-025-04294-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-025-04294-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T08:28:34Z","timestamp":1749112114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13205-025-04294-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4294"],"URL":"https:\/\/doi.org\/10.1007\/s13205-025-04294-6","relation":{},"ISSN":["2190-572X","2190-5738"],"issn-type":[{"value":"2190-572X","type":"print"},{"value":"2190-5738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study has been performed in accordance with the Declaration of Helsinki and was approved by Institutional Research Ethics Committee of the Zhejiang Provincial People\u2019s Hospital, and written informed consent was obtained from all patients.Consent for publication.Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"177"}}